Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) Earns 0 Analysts Hold Rating
Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) registered a 5.21% increase, still its new closing price is 28.95% up from the company’s 1 year high of 0.64.It posted -1.96% …
Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) registered a 5.21% increase, still its new closing price is 28.95% up from the company’s 1 year high of 0.64.It posted -1.96% …